A human obesity-associated MC4R mutation with defective Gq/11α signaling leads to hyperphagia in mice

Peter J. Metzger,Aileen Zhang,Bradley A. Carlson,Hui Sun,Zhenzhong Cui,Yongqi Li,Marshal T. Jahnke,Daniel R. Layton,Meenakshi B. Gupta,Naili Liu,Evi Kostenis,Oksana Gavrilova,Min Chen,Lee S. Weinstein
DOI: https://doi.org/10.1172/jci165418
IF: 19.456
2024-02-16
Journal of Clinical Investigation
Abstract:Melanocortin 4 receptor (MC4R) mutations are the most common cause of human monogenic obesity and are associated with hyperphagia and increased linear growth. While MC4R is known to activate G s α/cAMP signaling, a substantial proportion of obesity-associated MC4R mutations do not affect MC4R/G s α signaling. To further explore the role of specific MC4R signaling pathways in the regulation of energy balance, we examined the signaling properties of one such mutant, MC4R (F51L), as well as the metabolic consequences of MC4RF51L mutation in mice. The MC4RF51L mutation produced a specific defect in MC4R/G q/11 α signaling and led to obesity, hyperphagia, and increased linear growth in mice. The ability of a melanocortin agonist to acutely inhibit food intake when delivered to the paraventricular nucleus (PVN) was lost in MC4RF51L mice, as well as in WT mice in which a specific G q/11 α inhibitor was delivered to the PVN; this provided evidence that a G s α-independent signaling pathway, namely G q/11 α, significantly contributes to the actions of MC4R on food intake and linear growth. These results suggest that a biased MC4R agonist that primarily activates G q/11 α may be a potential agent to treat obesity with limited untoward cardiovascular and other side effects.
medicine, research & experimental
What problem does this paper attempt to address?